Exact Mass: 527.2784
Exact Mass Matches: 527.2784
Found 124 metabolites which its exact mass value is equals to given mass value 527.2784
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ala Phe Lys Tyr
Ala Phe Tyr Lys
Ala Lys Phe Tyr
Ala Lys Tyr Phe
Ala Tyr Phe Lys
Ala Tyr Lys Phe
Phe Ala Lys Tyr
Phe Ala Tyr Lys
Phe Phe Lys Ser
Phe Phe Ser Lys
Phe His Lys Pro
Phe His Pro Lys
Phe Lys Ala Tyr
Phe Lys Phe Ser
Phe Lys His Pro
Phe Lys Pro His
Phe Lys Ser Phe
Phe Lys Tyr Ala
Phe Pro His Lys
Phe Pro Lys His
Phe Ser Phe Lys
Phe Ser Lys Phe
Phe Tyr Ala Lys
Phe Tyr Lys Ala
His Phe Lys Pro
His Phe Pro Lys
His Lys Phe Pro
His Lys Pro Phe
His Pro Phe Lys
His Pro Lys Phe
Lys Ala Phe Tyr
Lys Ala Tyr Phe
Lys Phe Ala Tyr
Lys Phe Phe Ser
Lys Phe His Pro
Lys Phe Pro His
Lys Phe Ser Phe
Lys Phe Tyr Ala
Lys His Phe Pro
Lys His Pro Phe
Lys Pro Phe His
Lys Pro His Phe
Lys Ser Phe Phe
Lys Tyr Ala Phe
Lys Tyr Phe Ala
Pro Phe His Lys
Pro Phe Lys His
Pro His Phe Lys
Pro His Lys Phe
Pro Lys Phe His
Pro Lys His Phe
Pro Gln Gln Arg
Pro Gln Arg Gln
Pro Arg Gln Gln
Gln Pro Gln Arg
Gln Pro Arg Gln
Gln Gln Pro Arg
Gln Gln Arg Pro
Gln Arg Pro Gln
Gln Arg Gln Pro
Arg Pro Gln Gln
Arg Gln Pro Gln
Arg Gln Gln Pro
Ser Phe Phe Lys
Ser Phe Lys Phe
Ser Lys Phe Phe
Tyr Ala Phe Lys
Tyr Ala Lys Phe
Tyr Phe Ala Lys
Tyr Phe Lys Ala
Tyr Lys Ala Phe
Tyr Lys Phe Ala
Fesoterodine Fumarate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Fesoterodine Fumarate is an orally active, nonsubtype selective, competitive muscarinic receptor (mAChR) antagonist with pKi values of 8.0, 7.7, 7.4, 7.3, 7.5 for M1, M2, M3, M4, M5 receptors, respectively. Fesoterodine Fumarate is used for the overactive bladder (OAB)[1][2].
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate maleate
(2S)-N-[(4S,4aR,6R,8S,8aR)-8-methoxy-7,7-dimethyl-6-[[(2R)-5-oxooxolan-2-yl]methyl]-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-4-yl]-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide
(2S,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
n-[(1e,5r)-5-{4-hydroxy-5-[(2e,4e,9e,12e)-8-hydroxy-2,5,9-trimethyltetradeca-2,4,9,12-tetraenoyl]-6-oxopyran-2-yl}hex-1-en-1-yl]methoxycarboximidic acid
n-[(1e,5r)-5-{4-hydroxy-5-[(2e,4e,8r,9z,12e)-8-hydroxy-2,5,9-trimethyltetradeca-2,4,9,12-tetraenoyl]-6-oxopyran-2-yl}hex-1-en-1-yl]methoxycarboximidic acid
aconosine; o14-(4-methoxybenzoyl),13-hydroxy
{"Ingredient_id": "HBIN014590","Ingredient_name": "aconosine; o14-(4-methoxybenzoyl),13-hydroxy","Alias": "NA","Ingredient_formula": "C30H41NO7","Ingredient_Smile": "NA","Ingredient_weight": "527.65","OB_score": "NA","CAS_id": "131653-96-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7183","PubChem_id": "NA","DrugBank_id": "NA"}